A single-arm, open-label, long-term efficacy and safety study of subcutaneous (SC) romiplostim in children with immune thrombocytopenia (ITP)

Authors
Category Primary study
JournalBlood
Year 2016
This article has no abstract
Epistemonikos ID: be00441d492bfa96ddfef4df839311582ed8771e
First added on: Feb 08, 2025